A

Apogee Therapeutics, Inc.

HealthBiotechnology

Apogee Therapeutics, Inc. is focused on developing innovative therapies for atopic dermatitis and other conditions. The company is expanding its clinical trials into asthma and eosinophilic esophagitis (EoE), supported by a significant funding deal with Blackstone.

Visit website ↗
Total raised
$1.3B
tracked to date
Latest round
$1.3B
Jun 3, 2026
Known investors
1
led by Blackstone

Is this your company?

Claim this profile to get matched with investors who fund Health startups.

Claim this profile →

Funding history

  1. 1
    $1.3BJun 3, 2026

    Led by Blackstone

    Announcement ↗

Investors in Apogee Therapeutics, Inc.

Backers from this company's tracked funding rounds.

  • BBlackstoneLead investorVC firm

Apogee Therapeutics, Inc. in the news

Coverage of this company's funding, tracked by Datapile.

More Health companies

Recently funded startups in the same category.

Related on Datapile